Continuous glucose monitoring in the ICU: clinical considerations and consensus

摘要: Glucose management in intensive care unit (ICU) patients has been a matter of debate for almost two decades. Compared to intermittent monitoring systems, continuous glucose (CGM) can offer benefit the prevention severe hyperglycemia and hypoglycemia by enabling insulin infusions be adjusted more rapidly potentially accurately because trends concentrations readily identified. Increasingly, it is apparent that single target/range may not optimal all at times and, as with many other aspects critical patient management, personalized approach control appropriate. Here we consider some evidence supporting different targets various groups patients, focusing on those without diabetes neurological ICU patients. We also discuss reasons why, despite benefit, CGM devices are still widely employed propose areas research needed help move from arena routine clinical use.